JP2024513906A5 - - Google Patents

Info

Publication number
JP2024513906A5
JP2024513906A5 JP2023561609A JP2023561609A JP2024513906A5 JP 2024513906 A5 JP2024513906 A5 JP 2024513906A5 JP 2023561609 A JP2023561609 A JP 2023561609A JP 2023561609 A JP2023561609 A JP 2023561609A JP 2024513906 A5 JP2024513906 A5 JP 2024513906A5
Authority
JP
Japan
Prior art keywords
cells
amino acid
ipsc
cell
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023561609A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024513906A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/023347 external-priority patent/WO2022216624A1/en
Publication of JP2024513906A publication Critical patent/JP2024513906A/ja
Publication of JP2024513906A5 publication Critical patent/JP2024513906A5/ja
Pending legal-status Critical Current

Links

JP2023561609A 2021-04-07 2022-04-04 人工多能性幹細胞からアルファ-ベータt細胞を生成するための組成物および方法 Pending JP2024513906A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163171650P 2021-04-07 2021-04-07
US63/171,650 2021-04-07
PCT/US2022/023347 WO2022216624A1 (en) 2021-04-07 2022-04-04 Compositions and methods for generating alpha-beta t cells from induced pluripotent stem cells

Publications (2)

Publication Number Publication Date
JP2024513906A JP2024513906A (ja) 2024-03-27
JP2024513906A5 true JP2024513906A5 (cg-RX-API-DMAC10.html) 2025-04-11

Family

ID=81648457

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023561609A Pending JP2024513906A (ja) 2021-04-07 2022-04-04 人工多能性幹細胞からアルファ-ベータt細胞を生成するための組成物および方法

Country Status (9)

Country Link
US (1) US20220333074A1 (cg-RX-API-DMAC10.html)
EP (1) EP4320224A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024513906A (cg-RX-API-DMAC10.html)
CN (1) CN117441010A (cg-RX-API-DMAC10.html)
AR (1) AR125313A1 (cg-RX-API-DMAC10.html)
AU (1) AU2022255166A1 (cg-RX-API-DMAC10.html)
CA (1) CA3214473A1 (cg-RX-API-DMAC10.html)
TW (1) TW202305114A (cg-RX-API-DMAC10.html)
WO (1) WO2022216624A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL303269A (en) 2020-12-03 2023-07-01 Century Therapeutics Inc Genetically engineered cells and uses thereof
US20250066738A1 (en) * 2021-09-07 2025-02-27 Dana-Farber Cancer Institute, Inc. Induced pluripotent stem cells (ipsc), t-cell compositions and methods of use
IL314801A (en) 2022-02-22 2024-10-01 Juno Therapeutics Inc Proteinase 3 (PR3) Chimeric Autoantigen Receptor T Cells and Related Methods and Uses
CN119630695A (zh) 2022-06-08 2025-03-14 世纪治疗股份有限公司 表达cd16变体和nkg2d的遗传工程化细胞及其用途
CN120435498A (zh) 2022-11-10 2025-08-05 世纪治疗股份有限公司 具有抗-nectin4嵌合抗原受体的基因工程化细胞及其用途
EP4393942A1 (en) * 2022-12-29 2024-07-03 Keshihua (Nanjing) Biotechnology Co., Ltd Tcr, polypeptide, expression vector, host cell, pharmaceutical composition and method for obtaining tcr
WO2025101938A2 (en) 2023-11-10 2025-05-15 Century Therapeutics, Inc. Genetically engineered cells having multi-transmembrane domain chimeric antigen receptors utilizing g protein-coupled receptor scaffolds, and uses thereof
WO2025106626A1 (en) 2023-11-15 2025-05-22 Century Therapeutics, Inc. Genetically engineered cells expressing c-x-c chemokine receptor type 4, and uses thereof
WO2025237762A1 (en) 2024-05-14 2025-11-20 Englmeier Ludwig Matched t-cells and myeloid cells from cell culture
WO2026128475A1 (en) * 2024-12-09 2026-06-18 Century Therapeutics, Inc. Genetically engineered induced pluripotent stem cells and effector cells derived therefrom

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344321B1 (en) 1990-06-11 2002-02-05 Gilead Sciences, Inc. Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met
DE69334275D1 (de) 1992-08-21 2009-05-20 Univ Bruxelles Immunoglobuline ohne Leichtkette
GB9710807D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
US6140081A (en) 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
JP2002060786A (ja) 2000-08-23 2002-02-26 Kao Corp 硬質表面用殺菌防汚剤
US20040224385A1 (en) 2001-08-20 2004-11-11 Barbas Carlos F Zinc finger binding domains for cnn
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US7972854B2 (en) 2004-02-05 2011-07-05 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US8574179B2 (en) 2004-09-17 2013-11-05 Stp Swiss Therapeutic Products Ag Enhanced biomechanical stimulation device
DK3399025T3 (da) 2007-03-23 2025-06-16 Wisconsin Alumni Res Found Omprogrammering af somatiske celler
ES2587395T3 (es) 2008-06-04 2016-10-24 Cellular Dynamics International, Inc. Procedimientos para la producción de células IPS usando un enfoque no vírico
EP3450545B1 (en) 2008-10-24 2023-08-23 Wisconsin Alumni Research Foundation Pluripotent stem cells obtained by non-viral reprogramming
CA2753679C (en) 2009-02-27 2021-03-02 Cellular Dynamics International, Inc. Differentiation of pluripotent cells
EP4420730A3 (en) 2009-03-19 2024-11-13 The Johns Hopkins University Psma-targeting compounds and uses thereof
PT2816112T (pt) 2009-12-10 2018-11-20 Univ Iowa State Res Found Inc Modificação do adn modificada pelo efector tal
US9206394B2 (en) 2010-02-03 2015-12-08 The University Of Tokyo Method for reconstructing immune function using pluripotent stem cells
EP2601289B1 (en) 2010-08-04 2017-07-12 Cellular Dynamics International, Inc. Reprogramming immortalized b cells
WO2012109208A2 (en) 2011-02-08 2012-08-16 Cellular Dynamics International, Inc. Hematopoietic precursor cell production by programming
DE102012006356A1 (de) 2012-03-28 2013-10-02 Audi Ag Kraftfahrzeug, umfassend mehrere aktive oder passive Sicherheitsvorrichtungen
EP2853590B1 (en) * 2012-05-22 2018-11-07 The University of Tokyo Method for producing antigen-specific t cells
EP3789487A1 (en) * 2013-04-03 2021-03-10 Memorial Sloan Kettering Cancer Center Effective generation of tumor-targeted t-cells derived from pluripotent stem cells
WO2015143029A1 (en) 2014-03-18 2015-09-24 The Johns Hopkins University Psma-based molecular-genetic reporter system
AU2015290554A1 (en) 2014-07-18 2017-03-09 Kyoto University Method for inducing T cells for cell-based immunotherapy from pluripotent stem cells
WO2017070333A1 (en) 2015-10-20 2017-04-27 Cellular Dynamics International, Inc. Multi-lineage hematopoietic precursor cell production by genetic programming
JP6976960B2 (ja) * 2015-11-27 2021-12-08 カーサリクス プロプライエタリー リミテッド 遺伝子改変された細胞およびその使用
LT3444334T (lt) 2016-04-15 2021-12-10 Kyoto University Antigenui specifinių cd8 teigiamų t ląstelių indikavimo būdas
CN118546961A (zh) 2016-08-26 2024-08-27 贝勒医学院 用于细胞治疗的组成型活性细胞因子受体
JP7215994B2 (ja) 2016-09-06 2023-01-31 ザ チルドレンズ メディカル センター コーポレーション 人工多能性幹細胞由来の免疫細胞
KR102397771B1 (ko) 2016-09-23 2022-05-13 프레드 헛친슨 켄서 리서치 센터 부 조직적합성(h) 항원 ha-1에 대해서 특이적인 tcr 및 이의 용도
JP7212615B2 (ja) 2016-10-05 2023-01-25 フジフィルム セルラー ダイナミクス,インコーポレイテッド 多能性幹細胞からhlaホモ接合免疫細胞への指向分化方法
MX2019012017A (es) 2017-04-07 2020-02-12 Juno Therapeutics Inc Celulas modificadas que expresan antigeno de membrana especifico de prostata (psma) o una forma modificada del mismo y metodos relacionados.
CN110891967B (zh) 2017-04-18 2025-03-14 富士胶片细胞动力公司 抗原特异性免疫效应细胞
TW201908335A (zh) 2017-07-25 2019-03-01 美國德州系統大學評議委員會 增強之嵌合抗原受體及其用途
EP3684816B1 (en) 2017-09-22 2024-05-29 Kite Pharma, Inc. Chimeric polypeptides and uses thereof
EP3692057B9 (en) 2017-10-03 2023-10-04 Precision BioSciences, Inc. Modified epidermal growth factor receptor peptides for use in genetically-modified cells
AU2018395397A1 (en) * 2017-12-28 2020-08-06 Gritstone Bio, Inc. Antigen-binding proteins targeting shared antigens
AU2019345052B2 (en) 2018-09-19 2025-09-04 FUJIFILM Cellular Dynamics, Inc. Protein L for activation and expansion of chimeric antigen receptor-modified immune cells
JP2022510207A (ja) * 2018-12-02 2022-01-26 フェイト セラピューティクス,インコーポレイテッド 増強されたiPSC派生エフェクター細胞を使用した免疫療法
AU2020218446B2 (en) * 2019-02-04 2023-05-25 National University Corporation Ehime University "CAR LIBRARY AND scFv MANUFACTURING METHOD
BR112021016046A2 (pt) * 2019-02-15 2021-11-09 Editas Medicine Inc Células assassinas naturais modificadas (nk) para imunoterapia
WO2021154543A2 (en) * 2020-01-31 2021-08-05 City Of Hope TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FOR TREATMENT OF IL13Rα2 POSITIVE MALIGNANCIES

Similar Documents

Publication Publication Date Title
JP2024519515A5 (cg-RX-API-DMAC10.html)
US12404338B2 (en) Anti CD30 chimeric antigen receptor and its use
US20250002579A1 (en) Chimeric antigen receptors and methods of making
US12304935B2 (en) Immunomodulatory polypeptides and related compositions and methods
JP2023553419A5 (cg-RX-API-DMAC10.html)
JP2021019590A (ja) キメラ抗原レセプター分子の制御的発現のためのレンチウイルスベクター
JP2025501214A5 (cg-RX-API-DMAC10.html)
WO2019191120A1 (en) Guidance and navigation control proteins and method of making and using thereof
JP2022526372A (ja) HvG疾患の処置における使用のためのCAR
CN112204135B (zh) 一种表达cd3抗体受体复合物的免疫细胞及其用途
EP4127143A1 (en) Targeting tapasin and tap complex to improve cellular immune-compatibility
CN105802975B (zh) 靶向her2阳性肿瘤的细胞制备物及其用途
EP4678187A1 (en) Compound for use in the treatment of inflammatory bowel disease
CN117778328A (zh) 一种通用型bcma car-t细胞的增殖方法
CN121800931A (zh) 靶向cll1的增强型嵌合抗原受体及其应用
HK40030175A (en) Chimeric antigen receptors and methods of making
CN119331823A (zh) 用于工程化t细胞制备的病毒颗粒及其用途
CN116888148A (zh) 追踪基因工程化细胞的肽标志物
HK1232561A1 (en) Chimeric antigen receptors and methods of making
HK1232561B (en) Chimeric antigen receptors and methods of making